moneyheap
CTVA −24.30% on Nov 12 · Analysis updated Nov 12, 2026, 4:49 PM ET
Why is Corteva, Inc. Common Stock (CTVA) stock down?
Corteva fell about 24% on Nov 12 to $9.19 from a $12.14 close the day before. Volume was about 62.9M shares, roughly 4-5 times the recent daily level. The cause was its first standalone Q3 report after the Vylor seed separation. Revenue was $1.59B, down 9% and below the roughly $1.77B consensus. Adjusted EPS was $0.06 against $0.10 expected, and the company reported a loss from continuing operations. Management cut 2026 adjusted EBITDA guidance to $1.1B-$1.125B and EPS guidance to $0.76-$0.80. Latin America was the main weakness, with organic sales down 31% on volume down 24% and price down 7%. Brazil has high distributor inventory and farmers short of cash. Analysts called the report a stumble, and Morningstar expects more volatile results from a pure crop-protection company. New products and non-Latin-America regions were bright spots, and the dividend yield is high. Earlier legal overhangs are still unresolved: the state challenge to the separation and the chlorpyrifos suit. The stock hit a new 52-week low of about $9.14. A 24% drop on heavy volume could bring a short-term bounce, but estimate cuts and Brazil inventory destocking are likely to weigh for several months.
News behind the analysis
- Why is Corteva stock plunging today?Shares fell 18.8% to $9.86 and touched a 52-week low of $9.14 after Q3 results missed estimates and the 2026 profit outlook was cut. Brazil's agrichemicals market was the main cause.
- Corteva shares plunge as CEO warns Brazil slump will drag onOppenheimer said Corteva "stumbled out of the gate" in its first standalone report. The company cut its 2026 adjusted EBITDA outlook to $1.1B-$1.125B from about $1.3B.
- Stocks moving the most today: Live updatesCNBC reported that Corteva shares fell on a Q3 revenue miss. Revenue was $1.59B against $1.77B expected.
- Corteva Posts Downbeat Q3 Results, Joins Nvidia, Alvotech And Other Big Stocks Moving LowerQ3 EPS of $0.06 missed the $0.10 consensus. Sales of $1.59B missed the $1.764B estimate.
- Corteva shares slide after Brazil weakness prompts annual profit forecast cutShares fell to their lowest in a year. Morningstar expects more volatile results now that Corteva is a crop-protection-only company.
- Corteva craters 22% after quarterly results miss estimatesQ3 revenue fell 8.6% to $1.59B, $180M below estimates. EPS of $0.06 missed by $0.04, and the stock hit a 52-week low of $9.18.
- Corteva shares plunge 23% as earnings miss and weaker Brazil demand force guidance cutThe 2026 adjusted EPS outlook was cut to $0.76-$0.80. Latin America organic sales fell 31%, with high distributor inventories in Brazil.
- Corteva Slides After Weak Q3 Results and Brazil-Driven Outlook CutThe stock fell 24.2% on the day. Latin America volume fell 24% and price fell 7%, and the company reported a loss from continuing operations.
- Corteva Plunges 22.7% on EPS BeatMarket cap fell to about $6.2B after one of the stock's worst single-day declines.
- Corteva (CTVA) Revises 2026 Forecast Amid Brazil Crop Protection ChallengesThe new guidance is adjusted EBITDA of $1.1B-$1.125B and EPS of $0.76-$0.80. GuruFocus notes a 5.49% dividend yield, and says the stock was well above its GF Value estimate before the drop.
About Corteva, Inc. Common Stock
Corteva is an Indianapolis-based agriculture company that came out of the DowDuPont breakup in 2019. In late 2026 it split in two: the seed and genetics business (Pioneer brand) was spun off as a separate public company called Vylor, so CTVA now appears to be mainly a crop-protection company. That is why the share price dropped sharply, from about $80 to about $12.
How it makes money
After the split, Corteva earns most of its money selling crop-protection products to farmers and distributors around the world. These include herbicides, insecticides, fungicides and biologicals (products made from natural sources), with its own patented ingredients as well as off-patent products. It spends roughly 6–7% of revenue on research to develop new active ingredients. Before the split, seeds made up a bit over half of sales and crop protection the rest. Results for the standalone business are still new, so check the latest filings for current figures.
What usually moves CTVA
- Farmer income and crop prices
- Planted acres and pest or weather conditions
- Pricing pressure from cheaper generic chemicals, especially from China
- Launches of new active ingredients and biologicals
- How the market judges the Vylor spin-off and restructuring